The Marketplace
SYGNIS introduces 2view unique Western blot detection technology
SYGNIS introduces 2view unique Western blot detection technology
SYGNIS AG | May 10, 2018
SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard), today announced the introduction of 2view™, a unique detection method optimised for Western blotting, under its Expedeon brand name.  
eBook: Protein Prep 101 - Extracting Value
The Scientist Creative Services Team | May 9, 2018
Learn about common challenges to protein preparation protocols, typical protein isolation workflows, considerations when working with challenging samples, and how to confirm intact protein extraction with this eBook!
Bio-Rad Expedites Disease Biomarker Discovery and Drug Development with the Launch of Bio-Plex Pro Human Cytokine Screening Panel
Bio-Rad Expedites Disease Biomarker Discovery and Drug Development with the Launch of Bio-Plex Pro Human Cytokine Screening Panel
Bio-Rad Laboratories | May 7, 2018
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today announced the launch of the Bio-Plex Pro Human Cytokine Screening Panel, the first validated high-performance multiplex assay on the market. The panel can identify and quantify 48 different analytes linked to heart disease, autoimmunity and allergy, cancer, and many other conditions.
Enabling Faster Growth of Non-Aerobic Bacteria
The Scientist Creative Services Team | May 1, 2018
Culturing anaerobic, microaerophilic, and capnophillic bacteria is technically challenging and requires specialized equipment. Automated jar systems are an attractive alternative for bacterial cultivation, combatting inefficiencies while simultaneously boosting yield and quality assurance. Learn more with this white paper from Advanced Instruments!
Stars of the Show: Immune Cells in Cancer
The Scientist Creative Services Team | May 1, 2018
Immune cells are naturally able to identify and eliminate cancer cells, while cancer cells have developed methods to evade or outpace immune-mediated killing. Which immune cells are involved in the body's natural response against cancer? What are their mechanisms of action? How can a research identify and label these stars of the show? Find out with this poster from Bethyl Laboratories and The Scientist!
eBook: Visualizing Apoptosis as it Happens
The Scientist Creative Services Team | Apr 27, 2018
Apoptosis is a highly regulated and critical homeostatic process in multicellular organisms, with aberrations implicated in several pathological conditions, including cancer. Download this eBook to find out more about the intrinsic and extrinsic apoptosis pathways, the biochemical and morphological stages of apoptosis, and nuclear events during apoptosis!
New Entry-Level, Automated Titrators Accelerate Laboratory Productivity
New Entry-Level, Automated Titrators Accelerate Laboratory Productivity
Thermo Scientific | Apr 27, 2018
A new series of entry-level, automated potentiometric laboratory-grade titrators has been designed to make titrations easier, more reliable and more accurate than manual alternatives, across a wide range of QC/QA applications within food and beverage, drinking water, wastewater, chemical and petrochemical, personal care, agriculture and academic markets.
Chemyx: Tracing Fibers - From DiI to Modern Methods
Chemyx: Tracing Fibers - From DiI to Modern Methods
Chemyx Inc. | Apr 25, 2018
Visualizing neuronal connections is highly important for understanding brain organization and pathophysiology. However, this data has historically been obtained through invasive and often terminal procedures. Technological advances have permitted the development of a new era of neuroanatomical tracing techniques.   
Introduction of the epMotion® 5075 NGS solution for automated library preparation
Introduction of the epMotion® 5075 NGS solution for automated library preparation
Eppendorf | Apr 25, 2018
The Next Generation Sequencing (NGS) library preparation process is labor-intensive, requiring experience and attention to detail over hours.
Proteintech Group Acquires Manufacturer of Human Cell-Expressed Proteins, HumanZyme
Proteintech Group Acquires Manufacturer of Human Cell-Expressed Proteins, HumanZyme
HumanZyme | Apr 16, 2018
Proteintech Group, the benchmark in antibodies, today announces an agreement to purchase HumanZyme.  HumanZyme is a leading manufacturer of recombinant human proteins. Their proprietary human cell-expression system generates authentic human proteins that have greater biological activity and stability than competitors’ systems.